Anna L. Van Dorsten

NavDx (ctHPVDNA) recurrence detection in surgically treated human papillomavirus-associated oropharyngeal squamous cell carcinoma

Human papillomavirus (HPV+)-positivity in oropharyngeal squamous cell carcinoma (OPSCC) is a favorable prognostic indicator though 10–25% of patients will experience progressive disease within 3 years of treatment. This project assesses the validity of circulating tumor HPV DNA (...